|
Showing the most relevant articles for your search:AMEX:ANX | Date | Time | Source | Headline | Symbol | Company | | 04/27/2015 | 3:21AM | Analyst Ratings Network | Roth Capital Initiates Coverage on Mast Therapeutics (ANX) | AMEX:ANX | Mast Therapeutics, Inc. |
| 06/16/2014 | 8:00AM | PR Newswire (US) | Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC Trial | AMEX:ANX | Mast Therapeutics, Inc. |
| 04/14/2014 | 8:00AM | PR Newswire (US) | Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell Disease | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/10/2014 | 8:00AM | PR Newswire (US) | Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc. | AMEX:ANX | Mast Therapeutics, Inc. |
| 09/03/2013 | 8:00AM | PR Newswire (US) | Mast Therapeutics To Present At The Rodman & Renshaw 15th Annual Healthcare Conference On September 10 | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/11/2013 | 8:00AM | PR Newswire (US) | ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX" | AMEX:ANX | Mast Therapeutics, Inc. |
| 03/01/2013 | 4:11PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/28/2013 | 5:15PM | PR Newswire (US) | ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX" | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/28/2013 | 4:01PM | PR Newswire (US) | Adventrx To Develop ANX-188 For Complications Of Arterial Disease | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/26/2013 | 4:38PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/26/2013 | 8:00AM | PR Newswire (US) | ADVENTRX Reviews Data Supporting Development Of ANX-188 In New Indications | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/25/2013 | 8:00AM | PR Newswire (US) | ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4 | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/11/2013 | 8:00AM | PR Newswire (US) | ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/08/2013 | 5:27PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:ANX | Mast Therapeutics, Inc. |
| 02/05/2013 | 8:00AM | PR Newswire (US) | ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12 | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/30/2013 | 7:00AM | PR Newswire (US) | ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188 | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/18/2013 | 6:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/10/2013 | 9:55AM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/10/2013 | 9:55AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/04/2013 | 8:00AM | PR Newswire (US) | ADVENTRX Announces Appointment of Chief Financial Officer | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/03/2013 | 4:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/03/2013 | 4:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/03/2013 | 4:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/03/2013 | 4:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/03/2013 | 4:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/03/2013 | 6:07AM | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/03/2013 | 6:07AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:ANX | Mast Therapeutics, Inc. |
| 01/02/2013 | 8:00AM | PR Newswire (US) | ADVENTRX To Present At The 6th Annual OneMedForum Emerging Company Finance Conference On January 8 | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/19/2012 | 4:19PM | Edgar (US Regulatory) | Other Filing (40-app/a) | AMEX:ANX | Mast Therapeutics, Inc. |
| 12/19/2012 | 4:18PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:ANX | Mast Therapeutics, Inc. |
|
Showing the most relevant articles for your search:AMEX:ANX |
|